Literature DB >> 24786129

Parosteal osteosarcoma.

Jen-Fan Hang1, Paul Chih-Hsueh Chen.   

Abstract

Parosteal osteosarcoma is a rare malignant bone tumor arising from the bone cortical surface. It most commonly occurs in young women over the metaphyseal region, especially the long bones near the knee joint. Patients usually report a slow-growing mass for years. The tumor is characterized by its bland microscopic morphology, prone to be misdiagnosed as other benign tumors. In the absence of dedifferentiation, the prognosis is generally better than that of conventional osteosarcoma. Recent studies demonstrated distinctive cytogenetic abnormality resulting in amplification of the CDK4 and MDM2 genes, which may serve as markers for molecular diagnosis. In this article, we review the clinical, radiologic, and pathologic features of parosteal osteosarcoma and identify some diagnostic pitfalls, discuss the prognostic variables, and update recent molecular advances and their application in the diagnosis.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24786129     DOI: 10.5858/arpa.2013-0030-RS

Source DB:  PubMed          Journal:  Arch Pathol Lab Med        ISSN: 0003-9985            Impact factor:   5.534


  14 in total

1.  [Spindle-cell osteosclerotic bone lesion with MDM2 amplification].

Authors:  C Mogler; M Boxberg; C Knebel; W Weichert; K Wörtler; K Specht
Journal:  Pathologe       Date:  2018-03       Impact factor: 1.011

Review 2.  A review of imaging of surface sarcomas of bone.

Authors:  Kelly Harper; Paul Sathiadoss; Asif Saifuddin; Adnan Sheikh
Journal:  Skeletal Radiol       Date:  2020-07-17       Impact factor: 2.199

3.  Silencing of VEGF inhibits human osteosarcoma angiogenesis and promotes cell apoptosis via VEGF/PI3K/AKT signaling pathway.

Authors:  Ningning Peng; Shuming Gao; Xu Guo; Guangya Wang; Cai Cheng; Min Li; Kehun Liu
Journal:  Am J Transl Res       Date:  2016-02-15       Impact factor: 4.060

Review 4.  Molecular genetics of osteosarcoma.

Authors:  Kirby Rickel; Fang Fang; Jianning Tao
Journal:  Bone       Date:  2016-10-17       Impact factor: 4.398

5.  Is Chemotherapy Associated with Improved Overall Survival in Patients with Dedifferentiated Chondrosarcoma? A SEER Database Analysis.

Authors:  Lee D Cranmer; Bonny Chau; Jose G Mantilla; Elizabeth T Loggers; Seth M Pollack; Teresa S Kim; Edward Y Kim; Gabrielle M Kane; Matthew J Thompson; Jared L Harwood; Michael J Wagner
Journal:  Clin Orthop Relat Res       Date:  2022-04-01       Impact factor: 4.755

Review 6.  The potential of micelleplexes as a therapeutic strategy for osteosarcoma disease.

Authors:  Catarina Melim; Ivana Jarak; Francisco Veiga; Ana Figueiras
Journal:  3 Biotech       Date:  2020-03-02       Impact factor: 2.406

7.  GNAS mutations are not detected in parosteal and low-grade central osteosarcomas.

Authors:  Carolina Salinas-Souza; Carlos De Andrea; Michel Bihl; Michal Kovac; Nischalan Pillay; Tim Forshew; Alice Gutteridge; Hongtao Ye; M Fernanda Amary; Roberto Tirabosco; Silvia Regina Caminada Toledo; Daniel Baumhoer; Adrienne M Flanagan
Journal:  Mod Pathol       Date:  2015-08-07       Impact factor: 7.842

Review 8.  Review of Osteosarcoma and Current Management.

Authors:  Ryan A Durfee; Maryam Mohammed; Hue H Luu
Journal:  Rheumatol Ther       Date:  2016-10-19

9.  Parosteal Osteosarcoma: A Benign-Looking Tumour, Amenable to a Variety of Surgical Reconstruction.

Authors:  Yogi Prabowo; Achmad Fauzi Kamal; Evelina Kodrat; Marcel Prasetyo; Samuel Maruanaya; Toto Suryo Efar
Journal:  Int J Surg Oncol       Date:  2020-05-28

10.  Clinical Epidemiology of Low-Grade and Dedifferentiated Osteosarcoma in Norway during 1975 and 2009.

Authors:  Kjetil Berner; Tom Børge Johannesen; Øyvind S Bruland
Journal:  Sarcoma       Date:  2015-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.